Astrana Health, Inc. ASTH
32.94 USD +0.76 (+2.36%)
At closeNov 11, 2026, 4:42 PM EST
32.94 0.00 0.00%
After hours · Nov 11, 4:42 PM ET
32.15 Day range 33.28
18.08 52-week range 51.60
- YTD
- +32.77%
- 1 year
- +38.40%
News
prnewswire.com Foothill Regional Medical Center Recognized Among Healthgrades' 2027 America's 100 Best Hospitals for Orthopedic Surgery and Joint Replacement Foothill Regional Medical Center Earns Multiple National Recognitions for Orthopedic Excellence and High-Quality Patient Outcomes ALHAMBRA, Calif., Nov. 10, 2026 /PRNewswire/ -- Foothill Regional…
seekingalpha.com Astrana Health, Inc. (ASTH) Q3 2026 Earnings Call Transcript Astrana Health, Inc. ( ASTH ) Q3 2026 Earnings Call November 5, 2026 5:30 PM EST Company Participants Brandon Sim - President & CEO Chan Basho - CFO, COO & Corporate Secretary Conference Call…
benzinga.com Needham Maintains Buy on Astrana Health, Raises Price Target to $45 Needham analyst Matthew Shea maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $41 to $45.
marketbeat.com Astrana Health Q3 Earnings Call Highlights Astrana Health NASDAQ: ASTH reported record third-quarter revenue and adjusted EBITDA as growth in Medicare Advantage membership and full-risk contracts helped offset declines in Medicaid and…
benzinga.com Astrana Health Q3 2026 Earnings Call Transcript Astrana Health (NASDAQ:ASTH) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
zacks.com Astrana Health, Inc. (ASTH) Q3 Earnings Lag Estimates Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.01 per share a year ago.
benzinga.com Astrana Health Narrows FY2026 Sales Guidance from $3.800B-$4.100B to $3.900B-$4.000B vs $3.980B Est Astrana Health (NASDAQ:ASTH) narrows FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.900 billion-$4.000 billion vs $3.980 billion estimate.
benzinga.com Astrana Health Q3 EPS $0.26 Misses $0.45 Estimate, Sales $1.023B Beat $1.020B Estimate Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.45 by 42.22 percent. This is a 2500 percent increase over earnings of…
prnewswire.com Astrana Health, Inc. Reports Third Quarter 2026 Results Company to Host Conference Call on Thursday, November 5, 2026, at 2:30 p.m. PT/5:30 p.m.
seekingalpha.com Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity Utz Brands shares rose after entering into an agreement to be acquired by Intersnack, a privately held European leader in savory snacks. Shares of health care management company Astrana Health…
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to…
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are…
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to…
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are…
gurufocus.com Is It Too Late to Buy Astrana Health Inc (ASTH) After 4.7% Rally? GF Value Says Undervalued On October 09, 2026, Astrana Health Inc (ASTH) shares rose 4.7% to a current price of $37.55, within a 52-week range of $18.08 to $51.60. This movement reflects
prnewswire.com Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call ALHAMBRA, Calif., Oct. 9, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric,…
zacks.com Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again Astrana Health, Inc. (ASTH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to…
defenseworld.net Astrana Health, Inc. (NASDAQ:ASTH) Stock Rated “Moderate Buy” by Wall Street Analysts Astrana Health, Inc. (NASDAQ: ASTH - Get Free Report) has received an average rating of "Moderate Buy" from the ten brokerages that are covering the stock, Marketbeat.com reports. Two equities…
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are…
defenseworld.net Head to Head Review: Tenet Healthcare (NYSE:THC) and Astrana Health (NASDAQ:ASTH) Astrana Health (NASDAQ: ASTH - Get Free Report) and Tenet Healthcare (NYSE: THC - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies…
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH). Such investors are advised to…
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - ASTH NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are…
businesswire.com ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $ASTH--ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law.- benzinga.com Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.004 billion estimate.
benzinga.com Oppenheimer Initiates Coverage On Astrana Health with Outperform Rating, Announces Price Target of $53 Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $53.
benzinga.com Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55 Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $47 to $55.- benzinga.com Barclays Maintains Overweight on Astrana Health, Raises Price Target to $53 Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Overweight and raises the price target from $50 to $53.
- benzinga.com Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.001B Est Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.001 billion estimate.
- benzinga.com Astrana Health Q2 EPS $0.40 Beats $0.34 Estimate, Sales $972.520M Miss $985.716M Estimate Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.34 by 17.65 percent. This is a 110.53 percent increase over earnings of…
- benzinga.com TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $50 TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $45 to $50.
benzinga.com BTIG Maintains Buy on Astrana Health, Raises Price Target to $65 BTIG analyst David Joyce maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $50 to $65.
benzinga.com Airbnb To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday Wall Street analysts changed outlook on top names. Includes upgrades/downgrades. Check analyst ratings page for details on MCD, NKE, ABNB, LNTH, XYZ, ASTH, RNG, CELH.
benzinga.com UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments Medicare Advantage stocks surge as CMS finalizes 2027 rates. Read about the 2.48% base rate hike and the impact on CVS, UNH, and ALHC.
benzinga.com Crude Oil Rises Sharply; Sealed Air Posts Upbeat Earnings Dow Jones down 0.46% amid Iran-U.S. conflict, NASDAQ down 0.22% and S&P 500 down 0.39%. Energy sector up 1.8%, consumer discretionary down 1.7%. Sealed Air Corp beats earnings expectations. The Dow…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Astrana Health Posts Upbeat Q4 Earnings, Joins AeroVironment, Kratos Defense & Security Solutions And Other Big Stocks Moving Higher On Monday U.S. stock market lower on Monday, with Dow Jones down 150 points. Astrana Health Inc (ASTH) shares rose 29.5% after beating earnings estimates.
benzinga.com Earnings Scheduled For March 2, 2026 
benzinga.com Astrana Health Stock Slide Presents An Attractive Entry Point: Analyst Astrana Health shares fell 22% after CMS proposed modest Medicare Advantage growth, but analyst says sell-off looks overdone and long-term benefits may emerge.
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session 
benzinga.com This QXO Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday 
benzinga.com Earnings Scheduled For November 6, 2025 
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com S&P 500 Moves Higher; Under Armour Shares Tumble After Q1 Results 
benzinga.com SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday - benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com Earnings Scheduled For May 8, 2025 
benzinga.com Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.- benzinga.com Earnings Scheduled For February 27, 2025
- benzinga.com Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session